Ensuring Access to Psychedelic-Assisted Therapy in Rural Communities.
Psychedelic Medicine June 1, 2025 Olivia M Dhaliwal, Lukas Bobak, Brian S. Barnett
With several classical psychedelics being designated as breakthrough therapies and the recent review of a New Drug Application for 3,4-Methylenedioxymethamphetamine in the treatment of posttraumatic stress disorder, the likelihood of psychedelic medication becoming approved for clinical use in the United States is high. Psychedelic-assisted therapy (PAT) may have a high demand in rural America,...
DOI: 10.1089/psymed.2024.0018 (opens in new tab)
Full text (opens in new tab)
Rural psychiatry
Rural health disparities
Rural medicine access
Psychedelic-assisted therapy pat
+4